In Episode 796, we had Alina Chan on to talk about The Origin of Covid-19, and the new book that she co-authored, Viral: The Search for the Origin of COVID-19. 
And in this episode, we have the other co-author of the book, Matt Ridley on to talk more about the purpose, and journey of writing the book. 

Should we still be optimistic about the pandemic, and will anything good come out of it? Also, why is it so hard for anyone to look for the origin of the virus?

My new book Skip The Line is out! Make sure you get a copy wherever you get your new book!

Join You Should Run For President 2.0 Facebook Group, and we discuss why should run for president.

I write about all my podcasts! Check out the full post and learn what I learned at jamesaltucher.com/podcast.

Thanks so much for listening! If you like this episode, please subscribe to “The James Altucher Show” and rate and review wherever you get your podcasts:

Apple Podcasts

Stitcher

iHeart Radio

Spotify

Follow me on Social Media:

YouTube

Twitter

Facebook

------------

• What do YOU think of the show? Head to JamesAltucherShow.com/listeners and fill out a short survey that will help us better tailor the podcast to our audience!
• Are you interested in getting direct answers from James about your question on a podcast? Go to JamesAltucherShow.com/AskAltucher and send in your questions to be answered on the air!

------------

• Visit Notepd.com to read our idea lists & sign up to create your own!
• My new book, Skip the Line, is out! Make sure you get a copy wherever books are sold!
• Join the You Should Run for President 2.0 Facebook Group, where we discuss why you should run for President.
• I write about all my podcasts! Check out the full post and learn what I learned at jamesaltuchershow.com

------------

Thank you so much for listening! If you like this episode, please rate, review, and subscribe to “The James Altucher Show” wherever you get your podcasts: 

• Apple Podcasts
• iHeart Radio
• Spotify

Follow me on social media:

• YouTube
• Twitter
• Facebook
• LinkedIn